Members of Congress gave a letter to Biden in 2022 calling on him to exit the WHO, but only recently has Trump promised to withdraw from the corrupt organization. Despite this, every country, including the U.S., is still on the hook unless they opt out of the WHO’s International Health Regulations (IHR) by July 19, 2025.
According to this, the agreement centers on something called the PABS system, a global plan to share profits from so-called “pandemic pathogens.”
“They literally talk about pathogens with pandemic potential,” Roguski said. “They don’t need to have an actual outbreak.”
Roguski warns their goal is to build permanent mRNA infrastructure, fast-track approvals, and hand out billions in contracts—before a single case is reported.
If the U.S. doesn’t opt out, the WHO has the power to sniff around for money to be used in this gigantic, global money laundering business deal to make Big Pharma even bigger.
Not only does the U.S. need to opt out of ALL things WHO, the WHO needs to be eliminated. It’s nothing but a money laundering business plan to use up tax dollars on things that don’t affect health one iota.
A damning new study from the world-renowned Cleveland Clinic has confirmed that flu “vaccines” slash overall life expectancy by increasing the chance of being infected with influenza.
The study found that people who received the seasonal shots have a 26.9% higher chance of getting the flu compared to the unvaccinated.
The findings of the study were highlighted by esteemed British immunologist Dr. John Campbell.
In a video shared on his YouTube channel, Dr. Campbell explains:
“A large study at the Cleveland Clinic found out that the flu ‘vaccine’ – the influenza ‘vaccine’ – over the last Winter, wasn’t that effective.
“In fact, it had a negative efficacy of 26.9%.
“In other words, if you took this flu vaccine, you were 26.9% more likely – more likely – to get influenza.
“Now, unfortunately, the paper doesn’t give us details on how much money the pharmaceutical industry made from selling this ‘vaccine’ with negative efficacy.”
Big Pharma makes $6.3 billion annually on this “vaccine.”
(See link for article)
__________________
**Comment**
A Pentagon study by Wolfe revealed that those vaccinated against the flu were “36% more likely to get coronavirus.”
Secretary Robert F. Kennedy Jr. warned in March that people who receive flu “vaccines” are “4.4 times more likely” to suffer a non-influenza infection.
Originally, the flu vaccine was a measure to protect the elderly, but go here for a blast from the past when four scientists researching the Flu vaccine during the 1960s found it to be ineffective and refused to give it to their own families. The scientists state they were prevented from publishing their negative findings.
Now a recent Japanese study shows NO BENEFIT on hard outcomes: hospitalization and death. Another perfect example of how the massive push to vaccinate people for the flu has been a waste of time and effort. Do not expect to read about this in the news.
The flu vaccine doesn’t prevent the spread of the flu.
CDC admits flu vaccine failed 91% of the time against the current flu strain.
Cochran’s 2018 review of 52 clinical studies on flu vaccines found only 15% of the studies were well designed and conducted and concluded that recommendations for routine use of influenza vaccine as a routine public health measure was not supported by the published evidence base.
Yet, despite all evidence, DHHS is unveiling a ‘Universal Flu Vaccine.’
On May 1, 2025, the U.S. Department of Health and Human Services (DHHS) announced plans to develop a universal influenza vaccine that would eliminate the need for annual flu shots and offer protection against other pandemic influenza threats, including bird flu and respiratory disease caused by coronaviruses. The initiative, called “Generation Gold Standard,” will cost $500 million and reportedly combine “traditional vaccine technology” with modern tools. The “traditional” vaccine technology, called a beta-propiolactone (BPL)-inactivated, whole-virus platform, involves injecting people with a chemically altered version of the whole virus designed to make it harmless but still capable of stimulating the immune system.123
The announcement follows a recent study out of the Cleveland Clinic that found this year’s flu shot for the 2024-2025 flu season to be -26.9 percent effective and linked to an increased risk of influenza compared to unvaccinated individuals
“Generation Gold Standard is a paradigm shift,” said U.S. National Institutes of Health (NIH) director Jay Bhattacharya, MD, PhD. “It extends vaccine protection beyond strain-specific limits and prepares for flu viral threats—not just today’s, but tomorrow’s as well—using traditional vaccine technology brought into the 21st century.”1
The Generation Gold Standard initiative was made public the day after the DHHS announced that all newly developed vaccines will be required to undergo placebo-controlled clinical trials before receiving licensure. “Our commitment is clear: every innovation in vaccine development must be grounded in gold standard science and transparency, and subjected to the highest standards of safety and efficacy testing,” said DHHS Secretary Robert F. Kennedy, Jr.4
Some researchers questioned the decision to rely on what they consider an outdated and potentially inadequate approach. “This is a head-scratcher to me. This is puzzling,” Gregory Poland, MD, a vaccine expert from the Atria Academy of Science and Medicine in New York, told NPR. “We’re going back to technology that was used 40, 50 years ago or more. So this is a little surprising to me why you would go backwards to this technology? It’s a very old technology,” Poland says. “This is what influenza vaccines in the 40s, 50s and 60s looked like.”2
Dr. Poland suggested that newer technologies, such as the mRNA-based COVID shots, are safer and produce fewer side effects compared to whole inactivated virus vaccines, which he says typically produce high fevers and seizures and potentially scare patients away from getting vaccinated. “We have live attenuated nasal spray influenza vaccines. We have recombinant influenza vaccines. We have an mRNA-based influenza vaccine,” he says. “So why would you put all your eggs in one basket?”2
Researchers Warn of Underreported Injuries, Push for mRNA Vaccine Pause
While some experts criticize this approach as outdated, whole-virus vaccines, compared to mRNA (messenger ribonucleic acid) biologics technology, have been in use for decades and have well-documented safety profiles.5 Meanwhile, mRNA biologics have been at the center of ongoing controversy and public concern since mRNA COVID shots were approved for distribution by the FDA in December 2020.6
A 2024 study published in The Journal of American Physicians and Surgeons suggests that COVID-19 shots should never have been classified as vaccines in the first place. “COVID-19 modRNA vaccines were misclassifiedas traditional vaccines rather than gene therapy products, bypassing stricter regulatory requirements; and WHO guidelines from 2005 were used for nonclinical assessments, despite being outdated and inapplicable to modRNA vaccines,” epidemiologist Nicolas Hulscher, MPH said in a Substack post discussing the study findings.78 (See link for article)
______________
**Comment**
This ‘universal vaccine’ could enter clinical trials as early as next year and will be available to the public by 2029.
Robert F. Kennedy Jr.: How to Fix America’s Health Crisis as HHS Secretary
Ultimate Human Podcast with Gary Brecka
May 27, 2025
RFK unpacks our $1.9 TRILLION sick care system.
If you scroll to 29.00, you can hear RFK explain the unbelievable corruption in research today – how it is completely bought out by Big Pharma:
NIH allocates $46 BILLION a year to science
This money goes to 56,000 researchers worldwide
The researchers getting the money are ‘approved’ by the industry and are part of an ‘old boy’s network’ that knows what they can research and what they can say and what they can’t say. Nothing is allowed that will diminish corporate profits
Nothing is published that doesn’t support corporate profits
All of this is allowed to happen because there’s no research replication. Researchers are safe because they know nobody will replicate their study and they aren’t going to be proven wrong – even if they are wrong.
RFK states they are probably going to allocate about 20% of NIH money to replication studies.
RFK states they are probably going to STOP publishing in the Lancet, New England Journal of Medicine, JAMA, and other journals that are corrupt and create their own in-house journals in each of the institutions. Many of the heads of these corrupt journals have stated publicly that they are no longer ‘science’ journals but promoters of pharmaceutical products.
The interim report for the hearing names 15 government officials (plus the Committee Chair Ron Johnson R-WI) who knew the COVID-19 vaccines were causing heart damage and worked to conceal and delay the information to the public. In five reports from the Daily Clout we counted 73 individuals named. This is probably the tip of the iceberg. (Go to link for names as well as news video)
The Case for Chronic Lyme: A Medical Perspective With Dr. Cameron
Posted By: Laurie Martin
The Chronic Lyme Disease Controversy
I’ve been treating chronic Lyme disease for 37 years. In that time, I’ve witnessed firsthand the struggles of patients whose symptoms didn’t resolve after the standard course of antibiotics. I’ve also seen how the medical community has been deeply divided on the existence of chronic Lyme disease.
Many of my colleagues—some of whom I deeply respect—have argued with me over the years, insisting that chronic Lyme disease doesn’t exist. They believed that once a patient completes a prescribed course of antibiotics, any lingering symptoms must be the result of something else—an autoimmune response, lingering inflammation, or simply the wear and tear of everyday life. Some even suggested that the symptoms were psychological, a product of health anxiety rather than a persistent infection.
Their skepticism wasn’t entirely unfounded. The medical community places a high value on evidence-based medicine, and in the absence of a universally accepted diagnostic test for chronic Lyme disease, many physicians were unwilling to acknowledge what they couldn’t definitively prove. But for me, the proof wasn’t in a single test—it was in the patients I saw every day, the ones who continued to struggle with unrelenting fatigue, joint pain, cognitive dysfunction, neuropathy, and dysautonomia (POTS) long after their treatment ended.
A Shift in Perspective: Acknowledging Chronic Manifestations
While some colleagues remained rigid in their views, others began to recognize that Lyme disease could lead to serious, chronic complications. Over time, Lyme arthritis, Lyme encephalopathy, Lyme neuropathy, Chronic Neurologic Lyme, Neuropsychiatric Lyme, PANS, POTS, and PTLDS were increasingly acknowledged in medical literature. These weren’t vague, unproven conditions—these were well-documented manifestations of Lyme disease that had been observed in patients.
It was particularly interesting to see that many of my colleagues—who had once completely dismissed the idea of chronic Lyme disease—began to accept the concept of Post Treatment Lyme Disease Syndrome (PTLDS). They acknowledged that some patients remained ill after treatment, sometimes for years. They saw the ongoing fatigue, cognitive dysfunction, and pain that persisted long after the initial infection.
But even as they accepted PTLDS, many still refused to consider that a persistent tick-borne infection might be responsible for these symptoms. They viewed PTLDS as an immunologic response to a past infection rather than a sign that the bacteria were still present. This created a paradox—if they could acknowledge that patients were still sick, why couldn’t they entertain the idea that there was an active infection driving these symptoms?
The Importance of Keeping an Open Mind
There’s still so much we need to learn about Lyme disease, particularly in its chronic form. Dismissing the possibility of persistent infection without fully exploring the science doesn’t serve patients. Many Lyme patients feel abandoned by the medical community because they are told their symptoms aren’t real or that they shouldn’t still be sick. But I’ve seen too many cases where patients responded positively to additional treatment—sometimes with extended antibiotics, sometimes with a combination of therapies targeting co-infections like Babesia or Bartonella.
I’ve also seen how new research continues to challenge old assumptions. Studies have shown that Borrelia burgdorferi, the bacteria that causes Lyme disease, can persist in animal models even after antibiotic treatment. Other research suggests that biofilms and persister cells may allow the bacteria to evade treatment, potentially leading to chronic symptoms. While the debate continues, the evidence pointing toward persistent infection is growing.
What This Means for Patients
For patients who continue to suffer, the name of their condition—whether it’s called chronic Lyme disease, persistent Lyme infection, or PTLDS—is far less important than the reality they live with every day. What matters most is that we, as doctors, listen to our patients, acknowledge their suffering, and remain open to the possibility that Lyme disease is far more complex than we once believed.
The more I work with Lyme disease patients, the clearer it becomes—chronic Lyme disease is real. And for many, the right treatment can mean the difference between lifelong suffering and reclaiming their health.
We must continue asking the tough questions, challenging old beliefs, and keeping an open mind. Because at the end of the day, it’s not about proving a point—it’s about helping people get their lives back.
https://madisonarealymesupportgroup.com/2022/03/03/the-chronic-lyme-debate-part-2/ Federal Representatives have all been fixated on the Klempner antibiotic trials (which were stopped after three months) and have completely ignored the mountain of evidence from other studies and autopsy reports identifying persistent infection (chronic Lyme) following extensive antibiotic treatment.
Great article by microbiologist Holly Ahern where she takes the PTLDS moniker head-on showing that the actual number of those with persistent/chronic symptoms is more like 60%: https://madisonarealymesupportgroup.com/2019/02/25/medical-stalemate-what-causes-continuing-symptoms-after-lyme-treatment/Please spread the word on this as researchers seeing the falsely skewed low percentages of 10-20% aren’t going to see the relevance in studying this further. If; however, they see that 60% of patients are affected chronically, that puts the whole matter into a different urgent category. We need to point out CDC/NIH errors.
My Lyme Disease Patient Got Worse on Antibiotics—Until We Adjusted the Dose
Posted By: Dr. Daniel Cameron
He was ready to quit treatment.
The antibiotics were making him feel worse, not better—nausea, fatigue, and a sense that his body was shutting down. He told me, “Doc, I don’t think I can keep doing this.”
I knew we needed a new approach—but not necessarily a new medication. Instead, I asked: What if we adjusted the dose?
⚖️ When Less Is More
Instead of the standard full dose, we lowered it—just enough to reduce the burden on his system, while still targeting the infection. It was a small tweak, but the impact was big:
His side effects eased within days
His energy improved
And most importantly, his Lyme symptoms began to resolve
🧩 Why Individualized Treatment Matters
This case reminded me that Lyme disease treatment isn’t about pushing patients to the edge—it’s about meeting them where they are. If a full dose overwhelms the system, patients can’t heal. But the right adjustment? That can unlock progress.
Every patient’s journey is different. Sometimes, it’s not about starting over—it’s about finding the dose that works.
💡 A Gentle Nudge, Not a Full Detour
This patient didn’t need a new medication or a brand-new protocol. He just needed someone to see the bigger picture and make a targeted change. That one adjustment helped him stay the course—and ultimately, heal.
___________________
**Comment**
I wonder how many would have stayed the course if they would have known this information?
Dosage matters, in fact, according to Dr. Burrascano, blood levels of various drugs were undetectable in some patients, despite using the same exact CDC guideline of 200 mg of doxycycline.
BTW: I felt miserable on antibiotics while my husband felt better. Every person has their own response. Treating this with an individual approach is imperative as no two respond identically. This is why mainstream medicine is woefully unprepared and inexperienced in treating this.
Madison Area Lyme Support Group 